Package 27241-125-05

{"route": ["ORAL"], "spl_id": "933f695e-e4f4-4c75-80fc-aea9a30aa13d", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "upc": ["0327241125027", "0327241126024"], "unii": ["A6IEZ5M406"], "rxcui": ["616749", "728231"], "spl_set_id": ["8bfd1a61-547a-4847-ae4e-480b17da6272"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-125-02)", "package_ndc": "27241-125-02", "marketing_start_date": "20190823"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-125-05)", "package_ndc": "27241-125-05", "marketing_start_date": "20210714"}], "brand_name": "Ranolazine", "product_id": "27241-125_933f695e-e4f4-4c75-80fc-aea9a30aa13d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "27241-125", "generic_name": "Ranolazine", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ranolazine", "active_ingredients": [{"name": "RANOLAZINE", "strength": "500 mg/1"}], "application_number": "ANDA210054", "marketing_category": "ANDA", "marketing_start_date": "20190823", "listing_expiration_date": "20261231"}